消费者医疗保健市场规模、份额、成长分析（按产品、分销管道和地区）—2025-2032 年产业预测

预计到 2023 年，消费者保健市场规模将达到 2,923 亿美元，从 2024 年的 3,139.3 亿美元成长到 2032 年的 5,557.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.4%。

受老龄人口快速成长的推动，消费者保健市场将经历显着成长。根据世界卫生组织 (WHO) 报告，预计到 2050 年，中国 60 岁及以上成年人口将达到 21 亿。在这一人群中，消化不良和慢性疼痛等与老龄化相关的疾病数量激增，导致对非处方药 (OTC) 和膳食补充剂的需求增加。其消费者保健产品涉及健康促进、营养、口腔清洁用品和护肤等广泛领域。该行业的扩张受到多种因素的推动，包括自我治疗的上升、医疗保健成本的增加、对以患者为中心的护理的关注度的提高，以及从处方笺到非处方药的转变。此外，随着可支配收入的增加，人们对健康和预防性医疗保健的接受度不断提高，也进一步加强了消费者医疗保健领域。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究

消费者医疗保健市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 营养补充品
• 非处方药

消费者保健市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概览
• 百货公司
• 独立零售商
• 药房或药局
• 专业零售商
• 超级市场或大卖场

各地区消费者医疗保健市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Haleon plc（United Kingdom）
• Kenvue Inc.（USA）
• McKesson Corporation（USA）
• Sun Pharmaceutical Industries Limited（India）
• Zydus Wellness Limited（India）
• Procter & Gamble Co.（USA）
• Unilever plc（United Kingdom/Netherlands）
• Nestle Health Science（Switzerland）
• Reckitt Benckiser Group plc（United Kingdom）
• Sanofi Consumer Healthcare（France）
• Bayer Consumer Health（Germany）
• Pfizer Consumer Healthcare（USA）
• Johnson & Johnson Consumer Inc.（USA）
• Abbott Laboratories（USA）
• GlaxoSmithKline Consumer Healthcare（United Kingdom）
• Amway Corporation（USA）
• Herbalife Nutrition Ltd.（USA）
• Nature's Bounty Co.（USA）

结论和建议

Consumer Healthcare Market size was valued at USD 292.3 billion in 2023 and is poised to grow from USD 313.93 billion in 2024 to USD 555.73 billion by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The consumer healthcare market is set for substantial growth, driven by the rapidly increasing senior population, projected to reach 2.1 billion adults aged 60 and over by 2050, as reported by the World Health Organization. This demographic is experiencing a surge in age-related ailments, such as digestion issues and chronic pain, leading to higher demand for over-the-counter (OTC) medications and dietary supplements. Consumer healthcare products span health improvement, nutrition, oral, and skin care. The industry's expansion is fueled by rising self-medication trends, increasing healthcare costs, a greater focus on patient-centered care, and the shift from prescriptions to OTC options. Moreover, growing acceptance of wellness and preventive healthcare alongside higher disposable incomes further bolsters the consumer healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Consumer Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Consumer Healthcare Market Segments Analysis

Global Consumer Healthcare Market is segmented by Product, Distribution Channel and region. Based on Product, the market is segmented intoDietary Supplementsand OTC Pharmaceuticals. Based on Distribution Channel, the market is segmented into Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers and Supermarkets or Hypermarkets. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Consumer Healthcare Market

A significant driver of growth within the global consumer healthcare market is the positive shift in consumer attitudes toward health and wellness. As individuals become increasingly aware of the importance of preventive care and self-care, there is a notable trend toward seeking out non-prescription medications and nutritional products. This heightened awareness not only fuels market expansion but also contributes to a broader array of products becoming available to consumers. Consequently, as people prioritize their health and actively engage in self-care practices, the consumer healthcare market continues to flourish, reflecting the evolving needs and preferences of the population.

Restraints in the Consumer Healthcare Market

The progress of the global consumer healthcare market is significantly hindered by stringent regulations and compliance requirements. Manufacturers are compelled to adhere to comprehensive guidelines that govern product safety, efficacy, and marketing approaches. This necessity leads to elevated costs and prolonged timelines for launching new products, ultimately stifling innovation and leading to a stagnation in the development of essential offerings within the industry. As a result, the burdensome nature of these regulatory frameworks hampers the growth potential of the market, limiting the ability of companies to respond quickly to consumer needs and market trends.

Market Trends of the Consumer Healthcare Market

The consumer healthcare market is witnessing a robust trend toward personalization, driven by an increasing demand for tailored health solutions that cater to individual needs and preferences. This shift is fueled by advancements in data analytics and technology, enabling organizations to develop customized health regimens, targeted supplements, and personalized wellness services. By focusing on the unique health requirements of diverse consumers, companies not only enhance customer satisfaction and loyalty but also foster a deeper connection between brands and their clientele. As this trend continues to evolve, it is expected to shape the landscape of consumer healthcare, promoting innovation and improving overall health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Consumer Healthcare Market Size by Product & CAGR (2025-2032)

• Market Overview
• Dietary Supplements
• OTC Pharmaceuticals

Global Consumer Healthcare Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Departmental Stores
• Independent Retailers
• Pharmacies or Drugstores
• Specialist Retailers
• Supermarkets or Hypermarkets

Global Consumer Healthcare Market Size & CAGR (2025-2032)

• North America (Product, Distribution Channel)
  • US
  • Canada
• Europe (Product, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Haleon plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kenvue Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Wellness Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unilever plc (United Kingdom/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Consumer Healthcare (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Consumer Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Consumer Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Consumer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline Consumer Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amway Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife Nutrition Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Bounty Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations